Figure 9
From: In silico mutagenesis-based designing of oncogenic SHP2 peptide to inhibit cancer progression

Each plot represents the free energy landscape of all the mutated peptide complexes (B–E), and wild-type is shown in (A).
From: In silico mutagenesis-based designing of oncogenic SHP2 peptide to inhibit cancer progression

Each plot represents the free energy landscape of all the mutated peptide complexes (B–E), and wild-type is shown in (A).